Date

Friday 4 and Saturday 5 September, 2026

Location

Crowne Plaza Sydney Darling Harbour

Applications

Closed

Preceptorship in precision medicine in GI cancers

Don’t miss our premier annual educational event for senior trainees and junior consultants. 

Preceptorships are an excellent way to learn the current state of the art management of GI cancers, while networking with expert leaders. Taking part in a Preceptorship is a great first step towards an active role within the membership.

It is a heavily subscribed event with overwhelmingly positive reviews from past attendees, highlighting a strong educational focus. The preceptors are pre-eminent medical, surgical, radiation oncologists and community advocates from Australia and Aotearoa New Zealand.

Places are limited, and applications will be assessed before positions are confirmed. Applicants will be notified of the outcome by mid-June.

GI Cancer Trials will cover one night’s accommodation and flights (if applicable) for successful applicants. Further details, including approved funding amounts and travel arrangements, will be provided once places have been finalised.

Applications have now closed.

 

Thank you to our sponsors of this year’s Preceptorship

Major sponsor

 

 

Supporting sponsors

                                    

Preceptorship learning model

Preceptorships are intensive learning courses about treatment best practice developed  through the evolution of clinical trials. It is an interactive review of literature to understand the progress of treatment for GI cancers in the context of current treatment paradigms.

The format is that of a short course (two-day retreat), with active participation from attendees regarding reviewing papers and presenting cases. Preceptorships provide ~30 senior trainees and junior consultants with access to senior members who are leading cancer specialists (preceptors) for mentoring in small groups.

Preceptees engage with both current and historical data, ensuring a comprehensive understanding of relevant trials, treatment timelines, strengths, weaknesses, and emerging research directions. Preceptees have the opportunity to review papers, prepare a presentation, receive feedback both prior to and at the Preceptorship by their assigned Preceptor, and present at the Preceptorship. Content is decided independently by the preceptors to ensure the academic independence of the teaching material.

Convenors

Professor Lorraine Chantrill

Illawarra Shoalhaven Local Health District, Wollongong, NSW

A/Professor Amitesh Roy

Flinders Centre for Innovation in Cancer, Adelaide, SA

Preceptors

A/Professor Meg Barnet

Garvan Institute of Medical Research, Sydney, NSW

A/Professor Dan Croagh

Monash Health, Melbourne, VIC

Professor Chris Karapetis

Flinders Centre for Innovation in Cancer, Adelaide, SA

A/Professor Ben Lawrence

Waipapa Taumata Rau | University of Auckland, New Zealand

A/Professor Margaret Lee

Eastern and Western Health, Melbourne, VIC

Dr Shehara Mendis

Western Health and Cabrini Health, Melbourne, VIC

A/Professor Sharon Pattison

Health New Zealand Te Whatu Ora, New Zealand

Professor Nick Pavlakis

Royal North Shore Hospital, Sydney, NSW

A/Professor Nick Clemons

Peter MacCallum Cancer Centre, Melbourne, VIC

Professor Niall Tebbutt

Austin Health, Melbourne, VIC

Community advocate with lived experience

Tenielle Jordan

Assistant Convenors

Dr Han-Yang Lau

Flinders Centre for Innovation in Cancer, Adelaide, SA

Dr John Mak

GI Cancer Trials, New Zealand

Dr Jason Tong

Illawarra Shoalhaven Local Health District, Wollongong, NSW

Past Preceptorships